1887

Abstract

Children with autistic spectrum disorders (ASDs) tend to suffer from severe gastrointestinal problems. Such symptoms may be due to a disruption of the indigenous gut flora promoting the overgrowth of potentially pathogenic micro-organisms. The faecal flora of patients with ASDs was studied and compared with those of two control groups (healthy siblings and unrelated healthy children). Faecal bacterial populations were assessed through the use of a culture-independent technique, fluorescence hybridization, using oligonucleotide probes targeting predominant components of the gut flora. The faecal flora of ASD patients contained a higher incidence of the group ( clusters I and II) of bacteria than that of healthy children. However, the non-autistic sibling group had an intermediate level of the group, which was not significantly different from either of the other subject groups. Members of the group are recognized toxin-producers and may contribute towards gut dysfunction, with their metabolic products also exerting systemic effects. Strategies to reduce clostridial population levels harboured by ASD patients or to improve their gut microflora profile through dietary modulation may help to alleviate gut disorders common in such patients.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.46101-0
2005-10-01
2024-03-19
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/10/JM541014.html?itemId=/content/journal/jmm/10.1099/jmm.0.46101-0&mimeType=html&fmt=ahah

References

  1. Amann R. I., Ludwig W., Schleifer K.-H. 1995; Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev 59:143–169
    [Google Scholar]
  2. Baird G., Cass H., Slonims V. 2003; Diagnosis of autism. BMJ 327:488–493 [CrossRef]
    [Google Scholar]
  3. Bolte E. R. 1998; Autism and Clostridium tetani . Med Hypotheses 51:133–144 [CrossRef]
    [Google Scholar]
  4. Brook I. 1995; Clostridial infection in children. J Med Microbiol 42:78–82 [CrossRef]
    [Google Scholar]
  5. Finegold S. M., Molitoris D., Song Y. & 20 other authors; 2002; Gastrointestinal microflora studies in late-onset autism. Clin Infect Dis 35 (Suppl. 1):S6–S16 [CrossRef]
    [Google Scholar]
  6. Franks A. H., Harmsen H. J. M., Raangs G. C., Jansen G. J., Schut F., Welling G. W. 1998; Variations of bacterial populations in human feces measured by fluorescent in situ hybridization with group-specific 16S rRNA-targeted oligonucleotide probes. Appl Environ Microbiol 64:3336–3345
    [Google Scholar]
  7. Gibson G. R., Roberfroid M. B. 1995; Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr 125:1401–1412
    [Google Scholar]
  8. Harmsen H. J. M., Elfferich P., Schut F., Welling G. W. 1999; A 16S rRNA-targeted probe for detection of lactobacilli and enterococci in faecal samples by fluorescent in situ hybridization. Microb Ecol Health Dis 11:3–12 [CrossRef]
    [Google Scholar]
  9. Hatheway C. L. 1990; Toxigenic clostridia. Clin Microbiol Rev 3:66–98
    [Google Scholar]
  10. Knivsberg A. M., Reichelt K. L., Hoien T., Nodland M. 2002; A randomised, controlled study of dietary intervention in autistic syndromes. Nutr Neurosci 5:251–261 [CrossRef]
    [Google Scholar]
  11. Langendijk P. S., Schut F., Jansen G. J., Raangs G. C., Kamphuis G. R., Wilkinson M. H., Welling G. W. 1995; Quantitative fluorescence in situ hybridization of Bifidobacterium spp.with genus-specific 16S rRNA-targeted probes and its application in faecal samples. Appl Environ Microbiol 61:3069–3075
    [Google Scholar]
  12. Manz W., Amann R., Ludwig W., Vancanneyt M., Schleifer K. H. 1996; Application of a suite of 16S rRNA-specific oligonucleotide probes designed to investigate bacteria of the phylum cytophaga–flavobacter–bacteroides in the natural environment. Microbiology 142:1097–1106 [CrossRef]
    [Google Scholar]
  13. McCartney A. L. 2002; Application of molecular biological methods for studying probiotics and the gut flora. Br J Nutr 88 (Suppl. 1):S29–S37 [CrossRef]
    [Google Scholar]
  14. Sandler R. H., Finegold S. M., Bolte E. R., Buchanan C. P., Maxwell A. P., Vaisanen M. L., Nelson M. N., Wexler H. M. 2000; Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 15:429–435 [CrossRef]
    [Google Scholar]
  15. Shaw W., Kassen E., Chaves E. 1995; Increased urinary excretion of analogs of Krebs cycle metabolites and arabinose in two brothers with autistic features. Clin Chem 41:1094–1104
    [Google Scholar]
  16. Song Y., Liu C., Finegold S. Y. 2004; Real-time PCR quantification of clostridia in feces of autistic children. Appl Environ Micobiol 70:6459–6465 [CrossRef]
    [Google Scholar]
  17. Wing L. 1997; The autistic spectrum. Lancet 350:1761–1766 [CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.46101-0
Loading
/content/journal/jmm/10.1099/jmm.0.46101-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error